Screener
EGLE vs GNOM
Global X S&P 500 U.S. Revenue Leaders ETF vs Global X Genomics & Biotechnology ETF
Key differences
- EGLE costs 0.31% less per year.
- GNOM is significantly larger than EGLE — larger funds tend to be more liquid and less likely to close.
- GNOM has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| EGLE | GNOM | |
|---|---|---|
| Annual cost (TER) | 0.19% | 0.50% |
| Fund size (AUM) | $2M | $51M |
| Since | 2025 | 2019 |
| Dividend yield | 0.98% | 1.38% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +14.8% | +53.6% |
| CAGR 3Y | N/A | -2.6% |
| CAGR 5Y | N/A | -10.5% |
| Sharpe 3Y | N/A | -0.06 |
| Volatility 1Y | 10.60% | 26.15% |
| Max drawdown | -9.78% | -75.00% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to EGLE and GNOM
Explore further